Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (72)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- Two pathways to glomerular hematuria
- Autoantibodies amplify the initial IgA abnormality
- Mesangial expansion: More than one substrate
- Recurrent hematuria can follow a relapsing course
- Apply the IgA pathway to a clinical vignette
- Alternating GBM thinning and thickening
- COL4A5 variant type can influence severity
- Primary reading
Slide index & full transcript (72 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Other Glomerular Diseases
IgA nephropathy • Alport spectrum disorders
Morphology | Pathogenesis | Clinicopathologic diagnosis
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning outcomes
Distinguish immune-complex glomerular injury from inherited basement-membrane disease.
Explain the multistep pathogenesis and mesangial morphology of IgA nephropathy.
Interpret IgA immunofluorescence and electron-microscopy patterns.
Relate type IV collagen defects to Alport renal and extrarenal manifestations.
Use integrated clinical, family-history, LM, IF, and EM findings in differential diagnosis.
Slide 3 · Two pathways to glomerular hematuria
Feature
IgA nephropathy
Alport spectrum disorders
Primary mechanism
Aberrantly glycosylated IgA1; immune complexes
Inherited defects of type IV collagen
Main initial site
Mesangial immune deposits
Glomerular basement membrane network
Defining evidence
Mesangial IgA on IF
Collagen-IV–associated ultrastructural/genetic findings
Shared manifestations
Hematuria; variable proteinuria
Hematuria; later proteinuria
Slide 4 · Glomerular compartments relevant to diagnosis
Capillary loops
Mesangial region
Conceptual schematic — not a histologic specimen
What each modality resolves
LM: Proliferation and scarring
IF: Immunoglobulin identity and location
EM: Electron-dense deposits or GBM defects
Slide 5 · Clinical phenotype directs the tissue question
Hematuria
Macroscopic or microscopic
Proteinuria / renal dysfunction
Variable severity and time course
Tissue findings
LM + IF + EM
Etiologic interpretation
Immune deposition vs structural collagen defect
The same urinary phenotype may reflect very different mechanisms.
Slide 6 · Core mechanisms are not interchangeable
IgA nephropathy
Alport disorders
Abnormal IgA1 and immune complexes
Mesangial deposition and activation
IF identifies mesangial IgA
Inherited collagen-IV defects
Basement-membrane instability
EM / collagen staining / genetics assist
Slide 7 · IgA nephropathy: Defining features
Prominent IgA deposits in the glomerular mesangium are required for diagnosis.
Recurrent hematuria is characteristic; Proteinuria is often mild.
It is as the most common glomerulonephritis worldwide.
Severe podocyte injury may occasionally produce nephrotic syndrome.
Crescentic glomerulonephritis is an uncommon presentation.
Slide 8 · Mesangial localization is the central clue
Capillary loops
Mesangial IgA deposits
Conceptual schematic — not a histologic specimen
Source-defined hallmark
IgA deposits in mesangial regions
Possible associated C3 staining
LM alone may underestimate disease
Slide 9 · Normal IgA handling provides mechanistic context
IgA is the principal immunoglobulin in mucosal secretions.
Circulating IgA is mainly monomeric and relatively low in concentration.
Polymeric IgA is normally catabolized in the liver.
In IgA nephropathy, circulating polymeric IgA increases, but increased production alone does not explain injury.
Slide 10 · Abnormal IgA1 hinge-region glycosylation
Normal IgA1
Galactose-bearing O-glycans
Galactose-deficient IgA1
Reduced galactose-bearing O-glycans
Simplified native vector model of IgA1 hinge-region O-glycosylation; Not molecular scale
Slide 11 · IgA nephropathy: The proposed multihit sequence
Aberrant IgA1
Galactose-deficient O-linked glycans
Anti-IgA response
IgG autoantibodies may recognize abnormal IgA1
Immune complexes
Circulating or in situ complexes
Mesangial injury
Cell activation, complement, matrix and inflammation
Robbins frames this sequence as the favored model, not as a fully resolved initiating cause.
Slide 12 · A glycosylation defect is not simply IgA overproduction
Glomerular deposits contain predominantly polymeric IgA with abnormal glycans.
A key proposed defect concerns galactose-bearing O-linked glycans on the IgA1 hinge region.
The defect may be hereditary or acquired.
Abnormally glycosylated IgA provides a substrate for mesangial deposition and autoantibody recognition.
Slide 13 · Autoantibodies amplify the initial IgA abnormality
IgG autoantibodies may target structurally abnormal IgA1.
IgG–IgA interactions can generate circulating immune complexes.
The model explains why elevated IgA production alone is insufficient.
The source also allows mesangial deposition of abnormal IgA before local complex formation.
Slide 14 · Two routes to mesangial immune complexes
Circulating deposition
In situ formation
Aberrant IgA1 reacts with IgG
Preformed complexes circulate
Complexes become trapped in mesangium
Aberrant IgA1 deposits first
Antibody then binds deposited IgA1
Complex forms within mesangium
Slide 15 · Complement involvement in IgA nephropathy
Typical IgA-nephropathy IF
IgA: Mesangial dominant deposition
C3 and properdin: Often present
IgG or IgM: May be weaker
Usually absent or not prominent
C1q: Usually absent
C4: Usually absent
Supports alternative-pathway involvement
Slide 16 · Deposits translate into mesangial injury
Mesangial deposits
IgA-containing immune complexes
Cell activation
Mesangial proliferation and mediators
Matrix expansion
Extracellular matrix deposition
Glomerular injury
Leukocyte recruitment; Altered capillary function
A mesangial deposit is a stimulus for cellular and matrix responses, not merely a passive stain.
Slide 17 · Inflammatory amplification affects lesion severity
Activated mesangial cells release cytokines and growth factors.
These mediators further stimulate mesangial cells and recruit inflammatory cells.
Leukocytes contribute to injury but also aid clearance of immune complexes.
The balance between injury and repair helps explain heterogeneous biopsy patterns.
Slide 18 · Genetic susceptibility modifies risk
Familial occurrence and affected HLA-identical siblings support inherited susceptibility.
Associations have been reported with certain HLA and complement genotypes.
Genome-wide studies implicate MHC class II loci.
Genetic susceptibility does not identify a single obligatory initiating antigen.
Slide 19 · Mucosal exposures may influence abnormal IgA production
Respiratory and gastrointestinal exposure to environmental agents may increase abnormal IgA synthesis.
Viruses, bacteria, and dietary antigens have been implicated.
The precise initiating antigen remains unknown in the source account.
This context helps explain hematuria episodes temporally related to infection.
Slide 20 · Secondary IgA deposition: Relevant systemic settings
Clinical context
Source-supported rationale
Chronic liver disease
Defective hepatobiliary clearance of IgA complexes
Celiac disease
Increased frequency with altered intestinal mucosal barrier
Other intestinal disorders
Secondary IgA nephropathy may occur
Staphylococcal infection
Infection-associated IgA deposition may occur
Slide 21 · Primary and secondary IgA disease
Primary renal disease
Secondary IgA disease
Often an isolated glomerular process
Recurrent hematuria is frequent
Mesangial IgA remains the defining tissue feature
Associated with liver/intestinal disorders or infection
Systemic context can influence interpretation
IgA deposits alone do not establish primary disease
Slide 22 · Light microscopy: Wide morphologic spectrum
Observed pattern
Potential interpretation
Normal-appearing glomeruli
LM may fail to reveal the immune-deposition process
Mesangial expansion
More cells, matrix, deposits, or combinations
Endocapillary proliferation
Inflammatory/proliferative activity
Focal or segmental proliferation
Involves only some glomeruli or tuft segments
Crescentic lesion
Rare severe proliferative injury
Slide 23 · Mesangial expansion: More than one substrate
Capillary loops
Mesangial IgA deposits
Conceptual schematic — not a histologic specimen
Mesangial widening arises from
Increased mesangial-cell number
Extracellular matrix accumulation
Immune deposits or mixed causes
Slide 24 · Endocapillary and segmental activity
Endocapillary proliferation may accompany mesangial changes.
Focal proliferative lesions involve only some glomeruli.
Segmental disease may affect part of the tuft rather than its entirety.
The number of intracapillary leukocytes varies from case to case.
Slide 25 · Crescents identify an unusually severe phenotype
Crescentic glomerulonephritis is uncommon in ordinary IgA nephropathy.
Its appearance correlates with a rapidly progressive nephritic presentation in some patients.
Severity cannot be inferred from mesangial IgA staining alone.
Interpret crescents together with the entire injury pattern and clinical trajectory.
Slide 26 · Proliferative injury can leave a sclerotic residue
Focal injury
Localized active tuft lesion
Healing response
Resolution with structural repair
Segmental scarring
Secondary focal segmental sclerosis
Functional loss
Reduced functional glomerular reserve
Current biopsy activity and chronic scarring provide different kinds of information.
Slide 27 · Immunofluorescence establishes the diagnosis
Mesangial IgA deposition is characteristic and is required for the diagnosis.
C3 and properdin are frequently detected together with IgA.
IgG or IgM can be present in lower abundance.
Early complement components are usually absent.
Slide 28 · IgA immunofluorescence: Interpret the full panel
Target
Typical biopsy observation
Inference
IgA
Prominent mesangial staining
Defining immune deposit
C3 / properdin
Often present
Alternative-pathway involvement
IgG / IgM
May be present in lesser amounts
Mixed immune-component deposition
C1q / C4
Usually absent
Early complement pathway not typically prominent
Slide 29 · Electron microscopy confirms deposit localization
Electron-dense immune deposits are predominantly mesangial.
Capillary-wall deposits can occur but are usually sparse.
Electron microscopy complements rather than replaces IF identification of IgA.
LM and EM heterogeneity should be reconciled with the immune staining pattern.
Slide 30 · Three microscopy modalities answer different questions
Light microscopy
Normal → proliferative
Mesangial / endocapillary
Rare crescents
Immunofluorescence
Mesangial IgA
Often C3, properdin
Early complement usually absent
Electron microscopy
Electron-dense deposits
Predominantly mesangial
Sparse capillary deposits
Slide 31 · IgA diagnostic synthesis
Clinical phenotype
Hematuria ± proteinuria
Renal biopsy LM
Activity, matrix, sclerosis
IgA-predominant IF
Specific mesangial immunoglobulin
Deposit distribution
Mesangial electron densities
Biopsy findings are interpreted with secondary causes and clinical context in mind.
Slide 32 · Clinical expression ranges from silent to severe
Some patients have microscopic hematuria detected incidentally.
Others experience episodic gross hematuria after mucosal infection.
Proteinuria ranges from mild to nephrotic-range in severe podocyte injury.
A small minority present with acute nephritic or rapidly progressive disease.
Slide 33 · Recurrent hematuria can follow a relapsing course
Mucosal infection
Respiratory infection often precedes episode
Macroscopic hematuria
Visible blood may last several days
Resolution
Hematuria subsides between attacks
Recurrence
Episodes may recur after months
Conceptual time course without quantitative incidence or fixed individual timing
Slide 34 · Microscopic hematuria is a frequent presentation
Microscopic hematuria alone in about 30%–40% of patients.
Proteinuria may be present or absent in this group.
Detection depends on urinalysis rather than visible change in urine.
An initially mild presentation does not eliminate the need to assess longitudinal renal risk.
Slide 35 · Nephritic and nephrotic expressions are distinct
Acute nephritic syndrome in approximately 5%–10% of cases.
Rapidly progressive glomerulonephritis may occur in a subgroup with severe injury.
The nephrotic syndrome is less common and may reflect extensive podocyte damage.
The clinical syndrome and biopsy lesion should be described separately.
Slide 36 · Age and episodic symptoms provide diagnostic context
IgA nephropathy can affect any age group.
Older children and young adults are most commonly affected.
Gross hematuria may follow respiratory, gastrointestinal, or urinary tract infection.
Visible hematuria usually resolves over several days and may recur months later.
Slide 37 · Why prognosis is heterogeneous
Relatively preserved course
Progressive course
Many patients maintain stable renal function for decades
Hematuria may recur without immediate failure
Clinical follow-up distinguishes the trajectory
Sustained proteinuria and hypertension increase concern
Glomerulosclerosis indicates established structural injury
Progression may be prolonged rather than abrupt
Slide 38 · Long-term renal outcomes cohort
Chronic renal failure in 15%–40% of patients over about 20 years.
This is a historical textbook estimate rather than a personalized prediction.
Many patients maintain normal renal function for decades.
The observed course reflects marked heterogeneity in activity and chronic injury.
Slide 39 · Markers of greater progression risk
Feature
Clinicopathologic rationale
Older age at onset
Textbook-associated adverse course
Heavy proteinuria
More severe glomerular barrier injury
Hypertension
Concomitant clinical injury burden
More glomerulosclerosis
Established irreversible structural damage
Slide 40 · IgA deposits can recur after renal transplantation
IgA deposition in transplanted kidneys is frequent in the source account.
A recurrent deposit is not automatically equivalent to clinically progressive dysfunction.
That approximately 15% of patients with recurrent IgA deposits follow a similarly progressive course.
Histologic recurrence and clinically important recurrence should be distinguished.
Slide 41 · IgA nephropathy versus systemic IgA vasculitis
Feature
IgA nephropathy
IgA vasculitis (Henoch–Schönlein)
Distribution
Typically isolated renal disease
Skin, gastrointestinal tract, joints, kidneys
Renal deposits
Mesangial IgA
Often analogous mesangial IgA
Clinical clue
Episodic hematuria
Purpura with systemic manifestations
Mechanistic overlap
IgA-driven immune processes
Overlapping IgA-driven immune processes
Slide 42 · Apply the IgA pathway to a clinical vignette
Fictional teaching vignette
An older child has brief recurrent gross hematuria after respiratory illness.
Urinalysis also detects mild proteinuria.
Biopsy IF is dominated by mesangial IgA.
Questions
Which compartment is involved?
Which antibody class is essential to the diagnosis?
Why may LM show varied degrees of proliferation?
Teaching vignette — constructed for learning, not a real patient case
Slide 43 · Interpret the IgA vignette
Fictional teaching vignette
Recurrent post-infectious hematuria is compatible with the clinical pattern.
Mesangial IgA provides the decisive immunopathologic clue.
Activity and scar burden must still be documented.
Interpretation
Mesangium is the main deposit compartment.
IgA immunofluorescence is defining.
Mesangial activation, immune deposits, matrix and leukocytes vary.
Teaching vignette — constructed for learning, not a real patient case
Slide 44 · Alport spectrum: A structural glomerular disorder
Alport disorders are familial nephropathies associated with basement-membrane component mutations.
Classic severe Alport syndrome reflects defective type IV collagen assembly.
Hematuria is the common initial renal manifestation.
The full phenotype may combine progressive kidney injury, sensorineural hearing loss, and ocular changes.
Slide 45 · The glomerular collagen IV network requires α3, α4 and α5
α3 chain
α4 chain
α5 chain
Collagen IV α3–α4–α5 network
Variant affecting one essential chain → defective network assembly
Slide 46 · A defective chain compromises network assembly
Intact collagen IV network
Disordered network
Conceptual collagen-IV network topology; Not an image of glomerular basement membrane
Slide 47 · Collagen-IV mutations produce multisystem effects
The α3–α4–α5 collagen IV network is central to glomerular basement-membrane function.
Collagen IV also supports specialized basement membranes in the inner ear and eye.
Missense, splice-site, insertion and deletion variants are described.
The inheritance pattern depends on which collagen-IV gene is affected.
Slide 48 · Inheritance patterns in the Alport spectrum
Mode
Typical implications
X-linked
Majority of classic cases in Robbins; often severe disease in affected males
Autosomal recessive
Both sexes can manifest the full syndrome
Autosomal dominant / heterozygous
Often milder hematuria spectrum; progression remains possible
Slide 49 · X-linked Alport disease is frequently more severe in males
The textbook attributes approximately 85% of cases to X-linked inheritance.
Affected males often manifest the complete renal and extrarenal syndrome.
Heterozygous females commonly present with hematuria, but require surveillance.
Phenotype varies with the pathogenic variant; Not every carrier remains clinically mild.
Slide 50 · Penetrance and renal risk require contextual interpretation
Complete penetrance for classic X-linked Alport syndrome.
It reports that about 90% of affected males develop end-stage renal disease by age 40.
These figures describe the textbook’s reported cohorts and are not individualized predictions.
Less severe phenotypes occur within the broader collagen-IV disease spectrum.
Slide 51 · Early light microscopy may be deceptively normal
Glomeruli may appear normal by light microscopy early in Alport disease.
Early urinary blood loss reflects a molecular structural defect rather than required immune deposits.
Light microscopy becomes more abnormal as chronic scarring develops.
An unremarkable LM sample does not exclude inherited collagen-IV disease.
Slide 52 · Alternating GBM thinning and thickening
Thin segment
Thickened segment
Irregular alternation of attenuated and expanded GBM regions
Conceptual basement-membrane schematic — not an electron micrograph
Slide 53 · Lamina-densa splitting creates a basket-weave pattern
Central splitting / lamellation
Single dense layer
Reconverging layers
Layer separation produces the characteristic basket-weave description
Conceptual basement-membrane schematic — not an electron micrograph
Slide 54 · Electron microscopy provides structural evidence
Fully developed disease may show irregular GBM thickening alternating with attenuation.
Splitting and lamellation of the lamina densa can create a basket-weave appearance.
Similar basement-membrane alterations may occur in tubules.
These features are most informative within the clinical and familial context.
Slide 55 · Late Alport lesions evolve toward chronic scarring
Focal segmental glomerulosclerosis can occur as disease progresses.
Global glomerulosclerosis reflects more extensive permanent injury.
Tubular atrophy, interstitial fibrosis and vascular sclerosis may accompany late disease.
Underlying basement-membrane instability may increase podocyte vulnerability.
Slide 56 · Collagen IV staining complements morphology
Tissue/target
Textbook observation
Interpretive role
Glomerular / tubular BM
Classic X-linked disease may lack α3, α4, α5 staining
Supports disturbed collagen-IV network
Skin biopsy
Loss of α5 staining may be seen
Ancillary evidence in classic X-linked disease
Electron microscopy
Thinning, thickening, lamellation
Structural evidence of glomerular BM disorder
Slide 57 · The classic Alport phenotype spans three organ systems
Kidney
Hematuria → proteinuria → declining function
Inner ear
Sensorineural hearing loss
Eye
Lens, cataract and corneal abnormalities
One inherited basement-membrane network can affect multiple organs.
Slide 58 · Sensorineural hearing loss may be clinically subtle
Cochlear basement-membrane dysfunction produces sensorineural hearing deficits.
Auditory involvement can be mild or initially overlooked.
Sensitive auditory testing may be required.
Hearing impairment provides an important extrarenal clue to renal hematuria.
Slide 59 · Ocular lesions broaden the diagnostic phenotype
Lens dislocation and posterior cataracts.
Corneal dystrophy is another reported manifestation.
Eye findings reflect the role of collagen IV in ocular basement membranes.
Their coexistence with hematuria and hearing loss strengthens clinical suspicion.
Slide 60 · Alport renal presentation can evolve over years
Hematuria
Often earliest clinical finding
Proteinuria
May arise after years
GBM remodelling
Thinning, thickening and lamellation
Chronic kidney injury
Sclerosis, fibrosis and declining function
Conceptual progression; Timing and penetrance vary across variants
Slide 61 · Typical ages and chronology in classic disease
Urinary hematuria is often first detected between ages 5 and 20 years.
Proteinuria may arise later in the disease course.
Overt male renal failure between approximately ages 20 and 50 years.
A later-onset, milder course is possible within the spectrum.
Slide 62 · COL4A5 variant type can influence severity
The source associates large deletions affecting COL4A5 with earlier end-stage kidney disease in X-linked cases.
Type IV collagen assembly is impaired by different pathogenic variant classes.
Genotype–phenotype correlations vary and must not replace phenotype assessment.
Genetic findings support inheritance counseling and longitudinal follow-up.
Slide 63 · Mild Alport variants and thin GBM findings
Domain
Source-supported features
Clinical
Familial hematuria; sometimes mild or moderate proteinuria
Ultrastructure
Diffuse or segmental GBM attenuation; focal lack of lamina densa
Genetic background
Often heterozygous type IV collagen-related variants
Long-term outcome
May remain stable or develop renal decline and FSGS
Slide 64 · Basement-membrane thickness in the source text
Condition
Illustrative adult GBM width
Thin basement-membrane phenotype
Approximately 150–225 nm
Healthy adult reference in Robbins
Approximately 300–400 nm
Textbook ranges require careful EM processing and laboratory interpretation.
Slide 65 · A disease spectrum requires family-based interpretation
Milder heterozygous X-linked and autosomal variants may share clinical features with severe Alport syndrome.
Some relatives with apparently isolated familial hematuria may have severe disease.
Thin basement-membrane nephropathy overlaps genetically with collagen-IV disorders.
Genetic counseling and sustained clinical follow-up are important across the spectrum.
Slide 66 · IgA nephropathy versus Alport spectrum
Dimension
IgA nephropathy
Alport spectrum
Fundamental defect
Immune-complex deposition
Inherited collagen-IV network defect
Initial anatomic focus
Mesangium
GBM
IF
Mesangial IgA
Collagen-IV staining may be abnormal
EM
Mesangial electron-dense deposits
GBM thinning, thickening, lamellation
Extrarenal clues
Mucosal illness; secondary settings
Hearing loss; ocular anomalies; family history
Slide 67 · Diagnostic reasoning for persistent hematuria
Clinical pattern
Recurrent infection-linked? Progressive familial?
Family / systemic clues
IgA-associated disease vs hearing/ocular findings
Biopsy interpretation
Mesangial IgA deposits vs altered GBM ultrastructure
Etiologic conclusion
Integrate IF, EM and hereditary context
No single routine light-microscopic pattern distinguishes every patient.
Slide 68 · Compare two hematuria presentations
Fictional teaching vignette
Case A: Recurrent hematuria after respiratory illnesses; Mesangial IgA staining.
Case B: Familial hematuria with hearing impairment; EM reveals lamellated GBM.
Interpretation
Case A: IgA nephropathy is favored.
Case B: Alport-spectrum disease is favored.
Which test establishes each mechanism?
Teaching vignette — constructed for learning, not a real patient case
Slide 69 · Synthesis: Link mechanism to diagnostic observation
Disease group
Causal lesion
Best differentiating clue
IgA nephropathy
Aberrant IgA1 → immune complexes → mesangial activation
Mesangial IgA by immunofluorescence
Alport spectrum
Type IV collagen defect → GBM network instability
GBM ultrastructure, collagen-IV studies and family/genetic context
Both
Variable glomerular barrier injury and hematuria
Clinical phenotype alone may overlap
Slide 70 · Clinical reasoning check
Which source-supported lesion explains mesangial IgA with recurrent gross hematuria?
Why is isolated hematuria compatible with early Alport disease despite normal LM?
Which biopsy modality directly demonstrates lamina-densa lamellation?
Which Alport-associated extrarenal findings should be actively sought?
Why must secondary contexts be considered before labeling IgA nephropathy primary?
Slide 71 · Answers: Core discriminating principles
IgA immune-complex deposition and mesangial activation.
The primary collagen-IV structural defect can precede light-microscopic scarring.
Electron microscopy identifies GBM thickness changes and lamellation.
Sensorineural hearing abnormalities and characteristic ocular changes.
Liver, intestinal, and infection-associated conditions may cause secondary IgA deposition.
Slide 72 · Primary reading
Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th edition (2026).
Renal chapter: glomerular diseases; IgA nephropathy and Alport spectrum disorders.
Core diagnostic framework: clinical findings together with LM, IF, EM and genetic/family context.
Schematic drawings in this lecture are conceptual, editable and not patient images.